We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Genflow Biosciences Plc | GENF | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.08 | 5.26% | 1.60 | 08:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.60 | 1.60 | 1.60 | 1.52 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 01/12/2024 10:28 by marmiesz Trading pattern has been narrowed recently and I feel that this could break one way or another soon. It could be that the patent confirmation will trigger a positive move as this is due to be announced any time in the next weeks or months. Happy to keep adding as I have been over the last few weeks. Holding for long term as I'm an investor not a trader,Marmie |
Posted at 12/11/2024 15:23 by moneymunch Genflow Biosciences (LON:GENF) (OTCQB:GENFF)’Genflow Biosciences (LON:GENF) (OTCQB:GENFF) 1,767 followers 1d 🧬 Why Genflow Biosciences (LON:GENF) (OTCQB:GENFF)? 🧬 Genflow Biosciences offers investors a unique opportunity to support a #biotech company revolutionizing the #longevity field. Our innovative #SIRT6 work has led to recent attention, including being named "A Firm to Watch" by The Guardian. Learn more about #Genflow's investment story: #GENF #GENFF #invest #smallcap |
Posted at 17/9/2024 08:00 by moneymunch Hopefully not too long before full market appreciation as positive newsflow is delivered by Eric and his team. The previous Virtual Presentation 7/3/24 saw Jonathan Swann's 3% declaration a couple of weeks later followed by his 4.8% plus and the UK Institutional Investor, Premier Milton's 9% plus which was the catalyst for the rise in share price at that time, and so hopefully more of the same following this week's presentation, especially on the progress made and on the back of any significant news. Any interest from US Institutional investors would be a game changer. Anyways, looking forward to the next UPdate or two, in Eric we trust!!! Gla holders;-) |
Posted at 17/9/2024 06:15 by moneymunch Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConfe September 16, 2024 08:57 ET | Source: Virtual Investor Conferences Share LONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF OTCQB:GENFF), based in the UK, focused on pioneering gene therapies to decelerate the aging process, today announced that Dr Eric Leire, Chief Executive Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConfe DATE: September 19th TIME: 10:00 AM ET LINK:https ://bit.ly/3XjDJkL Available for 1x1 meetings: September 19 This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.virtualinvestorc About Genflow Biosciences Plc Founded in 2020, Genflow Biosciences Plc. (LSE:GENF) (OTCQB:GENFF), a biotechnology company headquartered in the UK with R&D facilities in Belgium, is pioneering gene therapies to decelerate the aging process, with the goal of promoting longer and healthier lives while mitigating the financial, emotional and social impacts of a fast-growing aging global population. Genflow’s lead compound, GF-1002, works through the delivery of a centenarian variant of SIRT6 gene which has yielded promising preclinical results. Scheduled to begin in 2025, Genflow’s clinical trial aims to explore the potential benefits of GF-1002 in treating MASH (Metabolic Dysfunction-Associat |
Posted at 26/6/2024 17:17 by moneymunch For markets: Betting on biotech's bounce back.The investment in Formation Bio signals a broader recovery in the biotech sector. With inflationary pressures easing and confidence building in the US economy's smooth descent, investors are flocking back to biotech, anticipating innovative breakthroughs. This trend suggests a revitalization of venture capital flow into biotech firms, supported by promising trial data and advanced AI applications. Investors should keep an eye on these developments for potential growth opportunities. |
Posted at 07/6/2024 07:38 by moneymunch News on Monday from Eric would be very timely. Gla holders:-)10th - 11th June 2024 - Organised by Longevity Technology who hold 3% of Genflow, the advisory panel includes Eric Verdin who sits on Genflow's Scientific Advisory Board, Aubrey de Grey who originally was a member of Genflow's SAB and Jim Mellon who was an investor in Genflow's IPO....All bodes well!!! Gla ;-) New international event program launches to bring longevity entrepreneurs and investors together. Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed to educate and connect investors with the vast potential within the longevity market. |
Posted at 04/6/2024 06:19 by moneymunch Cutting edge science with patents pending, compelling preclinical data progressing to human clinical trials, prestigious academic partners and a leading influential and distinguished hands on Scientific Advisory Board.Exponential upside potential and prospects!!! Will a Major Pharma/JV partner wait for positive trial results from Genflow's Nash Human Clinical Phase 1/2 trials planned for next year, or will one move early given how hot the Nash/Liver space is right now, as well as the promise of a rapidly expanding and evolving longevity market and the compelling nature of SIRT6's profound importance and influence over multiple disease targets associated with aging. Big news could at anytime, and any in time for next weeks event would certainly put Genflow centre stage. 10th - 11th June 2024 - Organised by Longevity Technology who hold 3% of Genflow, the advisory panel includes Eric Verdin who sits on Genflow's Scientific Advisory Board, Aubrey de Grey who originally was a member of Genflow's SAB and Jim Mellon who was an investor in Genflow's IPO....All bodes well!!! Gla ;-) New international event program launches to bring longevity entrepreneurs and investors together. Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed to educate and connect investors with the vast potential within the longevity market. The inaugural Founders Longevity Forum will take place at Olympia London during the renowned London Tech Week, focusing on a sector that is projected to exceed $600 billion by 2025. This partnership aims to foster meaningful connections between startups, venture capitalists (VCs), corporate venture capitalists (CVCs), family offices and CEOs leading the charge in longevity. Brent Hoberman, Co-Founder and Executive Chair of Founders Forum Group, said: “Longevity is becoming a mega trend as science makes increased healthspans more realistic, converging with a wider shift towards preventative healthcare. “We’ve noticed a need to connect top scientists and innovative startups with funds to help them turn their dreams into reality. By bringing together the best and brightest minds working on longevity today, we can galvanize progress in this area and transform the demographic landscape.” Taking place on New international event program launches to bring longevity entrepreneurs and investors together.4, the Founders Longevity Forum will address the investment opportunities across the longevity space, from established longevity business models such as diagnostics, longevity clinics and supplements, through to cutting-edge longevity biotech companies poised to revolutionize the biotech industry and transform society. The event will also benefit from an advisory panel that has decades of longevity and geroscience expertise between them; the panel includes Eric Verdin, Andrea Maier, Jim Mellon and Aubrey de Grey, with further members to be announced. “Multiple longevity events are happening and they’re all great, but few are specifically focused on bringing more investors into this rapidly accelerating field,” said Phil Newman, Founder and CEO, Longevity.Technology “We plan to stage events in London, Abu Dhabi and San Francisco initially to accelerate longevity investment globally, and catalyze a wave of innovation and collaboration that will redefine the future of human health.” “We’re keen to educate investors on the vast opportunities in longevity whilst fostering meaningful connections for startups and scaleups in this niche,” said Carolyn Dawson, CEO, Founders Forum Group. “Helping create these connections is central to our mission at Founders Forum Group as we seek to empower entrepreneurs at every stage of their journeys; with Longevity.Technology as our partner, we can forge formative alliances that propel longevity innovation.” |
Posted at 24/5/2024 06:15 by moneymunch 10th - 11th June 2024 - Organised by Longevity Technology who hold 3% of Genflow, the advisory panel includes Eric Verdin who sits on Genflow's Scientific Advisory Board, Aubrey de Grey who originally was a member of Genflow's SAB and Jim Mellon who was an investor in Genflow's IPO....All bodes well!!! Gla ;-)New international event program launches to bring longevity entrepreneurs and investors together. Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed to educate and connect investors with the vast potential within the longevity market. The inaugural Founders Longevity Forum will take place at Olympia London during the renowned London Tech Week, focusing on a sector that is projected to exceed $600 billion by 2025. This partnership aims to foster meaningful connections between startups, venture capitalists (VCs), corporate venture capitalists (CVCs), family offices and CEOs leading the charge in longevity. Brent Hoberman, Co-Founder and Executive Chair of Founders Forum Group, said: “Longevity is becoming a mega trend as science makes increased healthspans more realistic, converging with a wider shift towards preventative healthcare. “We’ve noticed a need to connect top scientists and innovative startups with funds to help them turn their dreams into reality. By bringing together the best and brightest minds working on longevity today, we can galvanize progress in this area and transform the demographic landscape.” Taking place on New international event program launches to bring longevity entrepreneurs and investors together.4, the Founders Longevity Forum will address the investment opportunities across the longevity space, from established longevity business models such as diagnostics, longevity clinics and supplements, through to cutting-edge longevity biotech companies poised to revolutionize the biotech industry and transform society. The event will also benefit from an advisory panel that has decades of longevity and geroscience expertise between them; the panel includes Eric Verdin, Andrea Maier, Jim Mellon and Aubrey de Grey, with further members to be announced. “Multiple longevity events are happening and they’re all great, but few are specifically focused on bringing more investors into this rapidly accelerating field,” said Phil Newman, Founder and CEO, Longevity.Technology “We plan to stage events in London, Abu Dhabi and San Francisco initially to accelerate longevity investment globally, and catalyze a wave of innovation and collaboration that will redefine the future of human health.” “We’re keen to educate investors on the vast opportunities in longevity whilst fostering meaningful connections for startups and scaleups in this niche,” said Carolyn Dawson, CEO, Founders Forum Group. “Helping create these connections is central to our mission at Founders Forum Group as we seek to empower entrepreneurs at every stage of their journeys; with Longevity.Technology as our partner, we can forge formative alliances that propel longevity innovation.” Key highlights of the Founders Longevity Forum: Exclusive event – The Founders Longevity Forum will host a minimum of 120 approved guests, including high-caliber investors, family offices, longevity founders and VIPs. Comprehensive program – guests will enjoy a half-day of content, a welcome reception, a full-day program and automatic registration for London Tech Week. Global reach – following the London event, the Founders Longevity Forum will travel to Abu Dhabi and San Francisco. Longevity takes center stage – The Longevity Village at London Tech Week will elevate this dynamic industry, showcasing the companies applying new technologies to extend human healthspan. |
Posted at 13/4/2024 07:35 by moneymunch 10th - 11th June 2024 - Organised by Longevity Technology who hold 3%. Gla ;-)New international event program launches to bring longevity entrepreneurs and investors together. Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed to educate and connect investors with the vast potential within the longevity market. The inaugural Founders Longevity Forum will take place at Olympia London during the renowned London Tech Week, focusing on a sector that is projected to exceed $600 billion by 2025. This partnership aims to foster meaningful connections between startups, venture capitalists (VCs), corporate venture capitalists (CVCs), family offices and CEOs leading the charge in longevity. Brent Hoberman, Co-Founder and Executive Chair of Founders Forum Group, said: “Longevity is becoming a mega trend as science makes increased healthspans more realistic, converging with a wider shift towards preventative healthcare. “We’ve noticed a need to connect top scientists and innovative startups with funds to help them turn their dreams into reality. By bringing together the best and brightest minds working on longevity today, we can galvanize progress in this area and transform the demographic landscape.” Taking place on New international event program launches to bring longevity entrepreneurs and investors together.4, the Founders Longevity Forum will address the investment opportunities across the longevity space, from established longevity business models such as diagnostics, longevity clinics and supplements, through to cutting-edge longevity biotech companies poised to revolutionize the biotech industry and transform society. The event will also benefit from an advisory panel that has decades of longevity and geroscience expertise between them; the panel includes Eric Verdin, Andrea Maier, Jim Mellon and Aubrey de Grey, with further members to be announced. “Multiple longevity events are happening and they’re all great, but few are specifically focused on bringing more investors into this rapidly accelerating field,” said Phil Newman, Founder and CEO, Longevity.Technology “We plan to stage events in London, Abu Dhabi and San Francisco initially to accelerate longevity investment globally, and catalyze a wave of innovation and collaboration that will redefine the future of human health.” “We’re keen to educate investors on the vast opportunities in longevity whilst fostering meaningful connections for startups and scaleups in this niche,” said Carolyn Dawson, CEO, Founders Forum Group. “Helping create these connections is central to our mission at Founders Forum Group as we seek to empower entrepreneurs at every stage of their journeys; with Longevity.Technology as our partner, we can forge formative alliances that propel longevity innovation.” Key highlights of the Founders Longevity Forum: Exclusive event – The Founders Longevity Forum will host a minimum of 120 approved guests, including high-caliber investors, family offices, longevity founders and VIPs. Comprehensive program – guests will enjoy a half-day of content, a welcome reception, a full-day program and automatic registration for London Tech Week. Global reach – following the London event, the Founders Longevity Forum will travel to Abu Dhabi and San Francisco. Longevity takes center stage – The Longevity Village at London Tech Week will elevate this dynamic industry, showcasing the companies applying new technologies to extend human healthspan. |
Posted at 14/9/2023 17:40 by moneymunch The next Longevity Investors Conference will be held in Gstaad on September 27-29 2023About Longevity Investors Conference (LIC) The Longevity Investors Conference is bringing together the world's leading longevity key opinion leaders and scientists, institutional and private investors, wealthy private individuals, family offices, and investment funds. The main aim of the event is to discuss the latest trends and opportunities but also to provide relevant insights into the longevity and rejuvenation industry. As an investors-only conference, the event is fully focused on investors. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
